Piazza Jonathan 4
4 · Silverback Therapeutics, Inc. · Filed Dec 8, 2020
Insider Transaction Report
Form 4
Piazza Jonathan
Chief Financial Officer
Transactions
- Purchase
Common Stock
2020-12-08$21.00/sh+11,904$249,984→ 11,904 total
Footnotes (1)
- [F1]The shares were purchased in the Issuer's initial public offering.